|
|
||||||||
Department of Surgery, University of Cincinnati, and Shriners Hospital for Children, Cincinnati, Ohio 45267
| |
ABSTRACT |
|---|
|
|
|---|
Previous studies suggest that elevated temperature stimulates protein degradation in skeletal muscle, but the intracellular mechanisms are not fully understood. We tested the role of different proteolytic pathways in temperature-dependent degradation of long- and short-lived proteins in cultured L6 myotubes. When cells were cultured at different temperatures from 37 to 43°C, the degradation of both classes of proteins increased, with a maximal effect noted at 41°C. The effect of high temperature was more pronounced on long-lived than on short-lived protein degradation. By using blockers of individual proteolytic pathways, we found evidence that the increased degradation of both long-lived and short-lived proteins at high temperature was independent of lysosomal and calcium-mediated mechanisms but reflected energy-proteasome-dependent degradation. mRNA levels for enzymes and other components of different proteolytic pathways were not influenced by high temperature. The results suggest that hyperthermia stimulates the degradation of muscle proteins and that this effect of temperature is regulated by similar mechanisms for short- and long-lived proteins. Elevated temperature may contribute to the catabolic response in skeletal muscle typically seen in sepsis and severe infection.
ubiquitin; skeletal muscle; temperature
| |
INTRODUCTION |
|---|
|
|
|---|
ONE OF THE METABOLIC HALLMARKS of sepsis is the catabolic response in skeletal muscle, mainly reflecting increased protein breakdown, in particular myofibrillar protein breakdown (15, 17). Although glucocorticoids and the proinflammatory cytokines tumor necrosis factor and interleukin-1 are important mediators of sepsis-induced muscle cachexia (24, 28, 29), previous studies suggest that the elevated temperature (fever) that typically accompanies sepsis and severe infection may contribute to the increase in muscle proteolysis (14). Thus when incubated rat muscles or cultured myotubes were subjected to hyperthermia, protein degradation increased (3, 22), and this effect of high temperature was especially pronounced in muscles from septic rats (14).
Intracellular protein degradation is regulated by multiple proteolytic pathways, including lysosomal, calcium-dependent, and energy-proteasome-dependent mechanisms (1, 15). Although previous studies suggest that hyperthermia stimulates nonlysosomal, calcium-independent proteolysis in incubated rat muscles (3) and increases the chymotrypsin-like activity of the 26S proteasome in cell-free fractions of C2C12 myotubes (22), the role of the proteasome-dependent pathway in temperature-induced muscle proteolysis needs to be further defined. For example, it is not known if the increase in protein degradation caused by elevated temperature is energy dependent or can be blocked by specific proteasome inhibitors. In addition, the differential effects of high temperature on long-lived and short-lived muscle proteins and the involvement of different proteolytic pathways in temperature-induced changes in the degradation of different classes of proteins are not known.
In the present study, the role of different proteolytic pathways in the
response to hyperthermia of both long-lived and short-lived proteins
was determined in cultured L6 myotubes. This was done by using specific
metabolic inhibitors, including the proteasome inhibitor
-lactone
(7), and by incubating the myotubes in normal or energy-depleting
medium. Results suggest that hyperthermia stimulates degradation of
both long-lived and (to a lesser extent) short-lived proteins and that
the effect of high temperature on the degradation of both classes of
proteins is energy and proteasome dependent.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture. L6 rat skeletal muscle cells were purchased from the American Type Culture Collection (Manassas, VA). Cells were grown and maintained as described in detail recently (25) and were used between passages 2 and 8. Cells were seeded in 24-well culture plates (2.5 × 104 cells/well) or 10-cm dishes (2.5 × 105 cells/dish). Experiments were performed when ~90% of the cells had formed myotubes. Cell viability was assessed by determining trypan blue dye (5%) exclusion.
The L6 muscle cell line was originally developed by Yaffe (27) from trypsin-suspended thigh muscle cells of newborn rats. During culture, the cells differentiate into multinucleated fibers that become cross-striated and develop contractility, thus resembling mature muscle cells. L6 muscle cells were used in previous studies examining the regulation of protein turnover, and results from those experiments suggest that the response in the myotubes to various treatments, including treatment with dexamethasone, calcium, and hormones, is similar to the response seen in vivo or in incubated intact muscles (9, 25, 26). Thus, although results obtained in vitro in cultured cells always need to be interpreted with caution, regulatory mechanisms of protein turnover in L6 myotubes are likely to reflect mechanisms in muscle cells in vivo.
Protein degradation. Protein degradation was measured by determining the release of TCA-soluble radioactivity from proteins labeled with L-[3,5-3H]tyrosine (New England Nuclear, Boston, MA) as described previously by Hong and Forsberg (19) and with modifications described in detail recently (25). For determination of long-lived protein degradation, myotube proteins were labeled with 1 µCi/ml of L-[3,5-3H]tyrosine for 48 h, and for measurement of short-lived protein degradation, myotubes were labeled with 2 µCi/ml of L-[3,5-3H]tyrosine for 1 h. Cells were then washed twice with Hank's balanced salt solution, and nonradioactive DMEM containing 2 mM tyrosine was added to the myotubes. Protein degradation was determined by measuring the release of TCA-soluble radioactivity during 6 h incubation at 37, 39, 41, or 43°C. Protein degradation was expressed as the percentage protein degraded per 6 h, calculated as described in detail elsewhere (25). The role of different proteolytic pathways in the regulation of protein degradation was assessed by treating the myotubes with inhibitors of the individual proteolytic pathways as described in RESULTS. The involvement of energy-dependent protein degradation was determined by adding 2-dinitrophenol (0.2 mM) to the culture medium. This treatment resulted in a substantial reduction of myotube ATP levels in a recent study from our laboratory (25).
To validate the method used here to measure protein degradation, control experiments were performed in which protein breakdown was assessed by determining the amount of free tyrosine released from the myotubes. Myotubes were incubated for 6 h at 37 or 41°C in tyrosine-free DMEM containing 0.5 mM cycloheximide. This was analogous to the method used to measure protein breakdown in incubated intact rat muscles (17, 24). Cycloheximide was present in the medium to prevent reincorporation of released tyrosine into protein during incubation. At the end of incubation, tyrosine was determined in the medium by high performance liquid chromatography, and cell protein was measured as described previously (17, 24).
Protein synthesis. Myotubes were cultured as described above for 6 h at 37, 39, 41, or 43°C. L-[3,5-3H]tyrosine (2 µCi/ml; 2 mM) was added to the medium during the last 1 h of incubation, and protein synthesis was assessed by determining the amount of radioactivity incorporated into TCA-precipitated proteins as described in detail recently (25).
mRNA levels. When mRNA levels were determined, myotubes were cultured in 10-cm dishes to increase the amount of tissue. Cells were cultured for 6 h pair-wise at 37 or 41°C, where after mRNA levels for ubiquitin, the proteasome subunit C7, m- and µ-calpain, and the muscle-specific calpain p94 and cathepsin B were determined by dot blot hybridization. RNA was extracted by the guanidinium thiocyanate-phenol-chloroform method (5) using an RNA STAT-60 kit (Tel-Test "B," Friendship, TX). Dot blot hybridization was carried out under stringent conditions [50% formamide, 5× SSC (1× SSC = 0.15 M NaCl, 0.015 M sodium citrate) at 56°C]. The cDNA probes were labeled with digoxigenin (DIG)-11-dUTP (Boehringer Mannheim, Indianapolis, IN) by random labeling. RNA was quantified by spectrophotometry and denatured by boiling for 5 min. Three amounts of RNA (20, 10, and 5 µg) from each sample were blotted on a nylon membrane (Boehringer Mannheim) using a Minifold II slot-blot filtration manifold (BioRad, Hercules, CA) and fixed to the membrane by ultraviolet cross-linking for 5 min. Prehybridization was carried out at 56°C for 4 h in a buffer consisting of 50% formamide, 7% SDS, 50 mM sodium phosphate (pH 7.0), 2% blocking reagent (Boehringer-Mannheim), 5× SSC, and 0.1% N-laurolysarcosine.
Hybridization was carried out overnight at 56°C in the same buffer with 25 ng/ml DIG-labeled cDNA probe. After hybridization, the membranes were washed twice in 2× SSC, 0.1% SDS for 5 min at room temperature and twice in 0.1 SSC, 0.1% SDS for 15 min at 68°C. Chemiluminescence was detected by using 4-DIG alkaline phosphatase-conjugated Fab fragment (37.5 mU/ml; Boehringer Mannheim) and the substrate CDP-Star (0.25 mM; Boehringer Mannheim). The membranes were then exposed to X-ray film (X-Omat, Eastman-Kodak, New Haven, CT) for 1-4 h, and the signal intensities were determined by densitometry. The ratio between the signal intensities at 41 and 37°C was calculated for the 5, 10, and 20 µg RNA dots, and the mean of these calculations was used for each experiment. The cDNA probes were obtained as described previously (25).
Statistics. Results are presented as means ± SE. Two-way analysis of variance followed by Tukey's test was used for statistical analysis, except in paired experiments, when paired Student's t-test was used.
| |
RESULTS |
|---|
|
|
|---|
Degradation of long-lived proteins. Under basal conditions
(37°C), long-lived proteins were degraded at a rate of ~10% per 6 h, similar to previous reports from our and other laboratories (19,
25). Subjecting the cultured L6 myotubes to hyperthermia resulted in
increased protein degradation, with a maximal effect of ~30% noted
at a temperature of 41°C (Fig 1). In
most subsequent experiments, protein degradation was measured at 37 or
41°C. Cell viability determined by trypan blue dye exclusion was
>98% at all temperatures tested. The increase in protein degradation
at higher temperatures noted here is similar to results in previous studies in which intact incubated rat muscles (3, 14) or cultured mouse
skeletal muscle cells (22) were subjected to hyperthermia.
|
To validate the method used here to measure protein degradation, control experiments were performed in which protein breakdown was assessed as release of free tyrosine from myotubes incubated in the presence of 0.5 mM cycloheximide. When myotubes were incubated for 6 h at 37 or 41°C, the release of tyrosine was 0.61 ± 0.08 and 0.83 ± 0.06 nmol/mg protein, respectively (n = 6 paired observations; P < 0.05 by Student's paired t-test). This increase in protein degradation (36%) was somewhat more pronounced than the increase noted in the [3H]tyrosine experiments (compare with Fig. 1). Because the results in the control experiments were expressed as nanomoles tyrosine per milligram protein, it is possible that the results were influenced by reduced amount of protein at the high temperature. Results were therefore also calculated as nanomoles tyrosine per well and were 2.11 ± 0.06 and 2.46 ± 0.05 nmol tyrosine/well at 37 and 41°C, respectively (+17%, P < 0.05 by Student's paired t-test).
To assess the involvement of different proteolytic pathways in the
hyperthermia-induced proteolysis, we next determined the effect of
elevated temperature on protein degradation in the presence of
different protease inhibitors. First, the role of lysosomal protein
degradation was assessed by treating the cells with 100 µM leupeptin
or 10 mM methylamine, substances and concentrations that have been
shown in other experiments to block lysosomal protein degradation (3,
20). The effect of hyperthermia (41°C) was almost identical in the
presence or absence of either of these substances, indicating that
lysosomal activity was not essential for the effect of hyperthermia on
protein degradation (Fig. 2). Protein
degradation was reduced by 10-15% by leupeptin and methylamine at
both temperatures, suggesting that basal protein breakdown in the
myotubes was partly regulated by lysosomal activity.
|
To determine the role of calcium-dependent proteolysis in the response
to hyperthermia, we next examined the effect of elevated temperature on
protein breakdown in the absence of calcium, in the presence of 100 µM of the calpain inhibitor E-64 (23), or with a combination of these
conditions. The effect of hyperthermia (41°C) was almost identical
in normal and calcium-free medium and in medium with E-64, suggesting
that hyperthermia-induced increase in protein degradation was
independent of calcium and calpain activity (Fig.
3). The lower protein breakdown rates noted at both temperatures in myotubes incubated without calcium suggest that
basal protein degradation was at least in part calcium dependent.
|
The role of the proteasome in temperature-induced increase in myotube
protein degradation was assessed by incubating cells in
energy-depleting medium or in medium containing 100 µM
N-acetyl-L-leucinyl-L-leucinal-L-norleucinal (LLnL) or 100 µM
-lactone. These treatments
substantially reduced basal protein degradation rates, consistent with
previous experiments using incubated intact rat muscles (8, 18). The
effect of hyperthermia (41°C) on protein breakdown was abolished in
myotubes treated with LLnL,
-lactone, or energy-depleting medium
(Fig. 4), suggesting that the increase in
protein degradation induced by elevated temperature is caused by an
energy-proteasome-dependent mechanism.
|
Degradation of short-lived proteins. To study the effect of
hyperthermia on the degradation of short-lived proteins, myotube proteins were labeled for 1 h with
[3H]tyrosine, where after the release of
TCA-soluble radioactivity was measured over 6 h as described previously
(25). As expected, the basal breakdown rate of short-lived proteins was
several times higher than that of long-lived proteins and was ~70%
per 6 h. In previous reports as well, the breakdown rate of short-lived proteins determined in a similar fashion as here was ~5-7 times higher than the breakdown rate of long-lived proteins (12, 13). It
should be noted that the technique used here to measure protein breakdown gives an average of breakdown rates for multiple individual proteins, and because the breakdown rates between individual proteins can vary substantially, results need to be interpreted with caution. Hyperthermia stimulated the degradation of short-lived proteins and
similar to the response of long-lived proteins, a maximum effect was
seen at 41°C (Fig. 5). The relative
effect of hyperthermia on the breakdown of short-lived proteins,
however, was smaller than that seen for long-lived proteins. Thus at
41°C, the degradation of short-lived proteins was increased above
basal level by ~5% compared with an ~20-30% increase of
long-lived protein degradation (compare with Fig. 1).
|
The role of different proteolytic pathways in the hyperthermia-induced
breakdown of short-lived proteins was tested in a similar way as
described above for long-lived proteins. Addition of leupeptin (100 µM) or methylamine (10 mM) to the culture medium did not prevent the increase in protein degradation seen at
41°C, suggesting that the effect of hyperthermia did not
require lysosomal proteolytic activity (Fig.
6). The effect of hyperthermia on the
degradation of short-lived proteins was also maintained in the presence
of E-64 and in the absence of calcium in the medium, suggesting that the effect of hyperthermia was not caused by calcium-dependent or
calpain-mediated protein breakdown (Fig.
7). To test the role of
energy-proteasome-dependent proteolysis for the temperature-induced increase in short-lived protein degradation, myotubes were next treated
with
-lactone or energy-depleting medium. Basal protein breakdown
rates were reduced by
-lactone, suggesting that the proteasome
participates in the regulation of short-lived muscle proteins (Fig.
8). The effect of hyperthermia on
short-lived protein degradation was abolished in the presence of
-lactone or energy-depleting medium, consistent with the concept
that energy-proteasome-dependent proteolysis regulates
temperature-induced degradation of short-lived muscle proteins.
|
|
|
Protein synthesis and myotube protein levels. To test whether
the effect of hyperthermia was specific for protein degradation, we
next examined the influence of elevated temperature on protein synthesis in the myotubes. As seen in Fig.
9, hyperthermia resulted in a
"dose-dependent" increase in protein synthesis. The effect of
hyperthermia on protein synthesis was less pronounced than that seen on
protein degradation and was not statistically significant until the
temperature was raised to 43°C.
|
Because both protein synthesis and breakdown rates were increased at high temperature, it was important to determine the overall catabolic effect of hyperthermia. This was done by measuring cell protein levels after incubating myotubes at 37 or 41°C for 6 h. Cell protein levels were reduced from 9.32 ± 0.11 to 8.69 ± 0.12 mg/well when cultured at 37 and 41°C, respectively (n = 6 paired observations; P < 0.05 by Student's paired t-test).
mRNA levels. To examine whether changes in proteolytic activity
at high temperature were accompanied by changes in the gene expression
of enzymes and various components of the different proteolytic
pathways, mRNA levels for cathepsin B, m- and µ-calpain, p94,
ubiquitin, and the proteasome subunit C7 were determined by dot blot
hybridization. Steady-state levels of the mRNAs examined here were not
altered significantly by elevated temperature (Fig. 10 and Table
1). It should be noted that Fig. 10 depicts
the results from one experiment, and Table 1 provides the results from
multiple experiments (n
6 for the different transcripts).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The present results confirm previous reports of increased protein degradation in cultured muscle cells (22) and intact incubated rat muscles (3, 14) subjected to hyperthermia. The results are important from a clinical standpoint because they suggest that fever, typically accompanying sepsis and severe infection, may contribute to the catabolic response seen in these conditions. The present finding of increased protein synthesis in myotubes at elevated temperatures differs from incubated intact rat muscles in which protein synthesis was not affected by hyperthermia (3, 14). The reason for this apparent discrepancy is not known but may be different regulation of protein synthesis in incubated intact rat muscles and cultured myotubes. The effect of hyperthermia on protein synthesis in cultured myotubes has not been reported previously.
Although the influence of hyperthermia on protein degradation in cultured myotubes was examined in a previous study by Morita et al. (22), the two reports differ in several important aspects. In the present study, the effect of hyperthermia on the degradation of both long- and short-lived proteins was examined, whereas in the report by Morita et al. (22), only long-lived proteins were studied. The overall catabolic effect of hyperthermia was determined here by including measurements of protein synthesis and cell protein levels, whereas in previous experiments (22), only protein degradation was measured. The involvement of proteasome and lysosomal protein breakdown was assessed by measuring proteasome and cathepsin activities at 37 and 40°C in the study by Morita et al. (22), whereas in the present report, the contribution of different proteolytic pathways to changes in actual protein breakdown rates was determined by using specific protease inhibitors.
The sensitivity of short-lived proteins to hyperthermia noted here is a novel finding. Although it is not known from the present experiments which specific proteins were degraded at an increased rate at the elevated temperature, there is evidence that many regulatory proteins are short lived (2), whereas the myofibrillar proteins probably make up the major part of long-lived proteins in muscle cells (4).
The main purpose of the present experiments was to determine the proteolytic mechanism(s) involved in temperature-dependent increase in muscle protein degradation. This was accomplished by using blockers of individual proteolytic pathways. Results from those experiments suggest that the hyperthermia-induced increase in both long-lived and short-lived protein degradation is energy-proteasome dependent and not dependent on lysosomal or calcium-activated proteolysis. A similar conclusion was reached in two previous reports as well (3, 22), but the present study expanded earlier experiments by using specific inhibitors of different proteolytic pathways and by examining the regulation of both long-lived and short-lived proteins.
Energy-proteasome-dependent proteolysis typically involves degradation of ubiquitinated proteins (1, 16, 21). Although in a recent study, mRNA levels for the proteasome subunits RC4 and RC8 and for the 19S subunits S4 and S7 as well as for ubiquitin were not increased in myotubes at high temperature (22), it is still possible that the increase in protein degradation noted here reflected degradation of ubiquitinated proteins by the 26S/20S proteasome. We recently found that increased activity in the ubiquitin-proteasome pathway is not necessarily accompanied by increased mRNA levels for the various components of this proteolytic pathway (25). In the present study, mRNA levels for ubiquitin and the proteasome subunit C7 were not influenced by elevated temperature, despite increased proteasome-dependent proteolysis, further supporting the concept that changes in proteolytic activity are not always accompanied by changes in the gene expression of enzymes and other components of the proteolytic pathway.
The relative increase in protein breakdown at high temperature was much smaller in the short-lived than in the long-lived protein pool, suggesting that short-lived protein degradation is less sensitive to regulation than long-lived protein breakdown. In other studies as well, evidence was found that the degradation of long-lived and short-lived proteins in muscle cells was differentially regulated. For example, glutamine inhibited the breakdown of long-lived but not short-lived proteins in cultured muscle cells (30). A similar lack of effect on short-lived protein degradation was found for insulin and insulin-like growth factor-I (12, 13).
Interestingly, the differential regulation of short-lived and long-lived proteins is not unique to the muscle cell. For example, in cultured L-132 human lung cells, depletion of polyamines resulted in inhibited degradation of long-lived proteins but increased degradation of short-lived proteins (6). Although most treatments result in a differential regulation of short- and long-lived protein degradation, the two classes are regulated in a similar fashion in some cell types and after certain stimuli. Thus in growing fibroblasts, an energy-dependent nonlysosomal process was responsible for the degradation of both short- and long-lived proteins (10).
Although the results in the present and a previous study (22) suggest that temperature-induced muscle protein breakdown is regulated by the proteasome, the mechanism by which hyperthermia induces increased proteasome-dependent proteolysis remains to be determined. A well-described consequence of hyperthermia is the induction of heat-shock proteins and it may be speculated that one or several of the heat-shock proteins are involved in the regulation of protein degradation during hyperthermia. Results in a previous study suggest that upregulated activity of the ubiquitin-activating enzyme E1 may be an additional mechanism of increased protein degradation at high temperature (11).
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-37908 and by Grants 8580 and 8610 from the Shriners of North America, Tampa, FL.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: P.-O. Hasselgren, Dept. of Surgery, Univ. of Cincinnati, 231 Bethesda Ave., Mail Location 558, Cincinnati, Ohio 45267-0558 (E-mail: hasselp{at}uc.edu).
Received 17 June 1999; accepted in final form 11 October 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Attaix, D,
and
D Taillandier.
The critical role of the ubiquitin-proteasome pathway in muscle wasting in comparison to lysosomal and Ca2+-dependent systems.
Adv Mol Cell Biol
27:
235-266,
1998.
2.
Bachmaier, A,
and
A Varshavsky.
The degradation signal in a short-lived protein.
Cell
56:
1019-1032,
1989[ISI][Medline].
3.
Baraccos, VE,
EJ Wilson,
and
AL Goldberg.
Effects of temperature on protein turnover in isolated rat skeletal muscle.
Am J Physiol Cell Physiol
246:
C125-C130,
1984
4.
Bates, PC,
and
DJ Millward.
Myofibrillar protein turnover: synthesis rates of myofibrillar and sarcoplasmic protein fractions in different muscles and the changes observed during postnatal development and in the response to feeding and starvation.
Biochem J
214:
587-592,
1983[ISI][Medline].
5.
Chomczynski, P,
and
N Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[ISI][Medline].
6.
Corella, D,
M Guillén,
JM Hernandez,
and
J Hernandez-Yago.
Effects of polyamine levels on the degradation of short-lived and long-lived proteins in cultured L-132 human lung cells.
Biochem J
334:
367-375,
1998.
7.
Dick, LR,
AA Cruikshank,
L Grenier,
FD Melandri,
SL Nunes,
and
RL Stein.
Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin
-lactone.
J Biol Chem
271:
7273-7276,
1996
8.
Fang, CH,
JJ Wang,
S Hobler,
BG Li,
JE Fischer,
and
PO Hasselgren.
Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats.
Clin Sci
95:
225-223,
1998[Medline].
9.
Fernandez, C,
and
RD Sainz.
Pathways of protein degradation in L6 myotubes.
Proc Soc Exp Biol Med
214:
242-247,
1997[Abstract].
10.
Gronostajski, RM,
AB Pardee,
and
AL Goldberg.
The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts.
J Biol Chem
260:
3344-3349,
1985
11.
Gropper, R,
RA Brandt,
S Elias,
CF Bearer,
A Mayer,
AL Schwartz,
and
C Aiechanover.
The ubiquitin-activating enzyme, E1, is required for stress-induced lysosomal degradation of cellular proteins.
J Biol Chem
266:
3602-3610,
1991
12.
Gulve, EA,
and
JF Dice.
Regulation of protein synthesis and degradation in L8 myotubes. Effects of serum, insulin, and insulin-like growth factors.
Biochem J
260:
377-387,
1989[ISI][Medline].
13.
Gulve, EA,
K Mabuchi,
and
JF Dice.
Regulation of myosin and overall protein degradation in mouse C2 skeletal myotubes.
J Cell Physiol
147:
37-45,
1991[ISI][Medline].
14.
Hall-Angerås, M,
U Angerås,
PO Hasselgren,
and
JE Fischer.
Effects of elevated temperature on protein breakdown in muscle from septic rats.
Am J Physiol Cell Physiol
258:
C589-C592,
1990
15.
Hasselgren, PO.
Pathways of muscle protein breakdown in injury and sepsis.
Curr Opin Clin Nutr Metab Care
2:
155-160,
1999[Medline].
16.
Hasselgren, PO,
and
JE Fischer.
The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.
Ann Surg
225:
307-316,
1997[ISI][Medline].
17.
Hasselgren, PO,
JH James,
DW Benson,
M Hall-Angerås,
DT Hiyama,
S Li,
and
JE Fischer.
Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin.
Metabolism
38:
634-640,
1989[ISI][Medline].
18.
Hobler, SC,
G Tiao,
JE Fischer,
J Monaco,
and
PO Hasselgren.
Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R30-R37,
1998
19.
Hong, DH,
and
NE Forsberg.
Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures.
Mol Cell Endocrinol
108:
199-209,
1995[ISI][Medline].
20.
Lowell, BB,
NB Ruderman,
and
MD Goodman.
Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle.
Biochem J
234:
237-240,
1986[ISI][Medline].
21.
Mitch, WE,
and
AL Goldberg.
Mechanisms of muscle wasting. The role of the ubiquitin- proteasome pathway.
N Engl J Med
335:
1897-1905,
1996
22.
Morita, S,
T Tsujinaka,
M Yano,
C Ebisui,
T Morimoto,
J Fujita,
A Ogawa,
M Taniguchi,
H Shiozaki,
and
M Monden.
Temperature-dependent enhancement of proteolysis in C2C12 myotubes in association with activation of 26S proteasome.
Biochem Biophys Res Commun
228:
813-818,
1996[ISI][Medline].
23.
Sorimachi, H,
S Ishiura,
and
K Suzuki.
Structure and physiological function of calpains.
Biochem J
328:
721-732,
1997.
24.
Tiao, G,
J Fagan,
V Roegner,
M Lieberman,
JJ Wang,
JE Fischer,
and
PO Hasselgren.
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids.
J Clin Invest
97:
339-348,
1996[ISI][Medline].
25.
Wang, L,
GJ Luo,
JJ Wang,
and
PO Hasselgren.
Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes.
Shock
10:
298-306,
1998[ISI][Medline].
26.
Wingertzahn, MA,
and
RS Ochs.
Calcium mediated proteolysis enhances calcium release in skinned L6 myotubes.
Recept Signal Transduct
7:
221-230,
1997[ISI][Medline].
27.
Yaffe, D.
Retention of differentiation potentialities during prolonged cultivation of myogenic cells.
Proc Natl Acad Sci USA
61:
477-483,
1968
28.
Zamir, O,
PO Hasselgren,
SL Dunkel,
JA Frederick,
T Higashiguchi,
and
JE Fischer.
Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis.
Arch Surg
127:
170-174,
1992[Abstract].
29.
Zamir, O,
W O'Brien,
R Thompson,
DC Bloedaw,
JE Fischer,
and
PO Hasselgren.
Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist.
Int J Biochem
26:
943-950,
1994[ISI][Medline].
30.
Zhou, X,
and
JR Thompson.
Regulation of protein turnover by glutamine in heat-shocked skeletal myotubes.
Biochim Biophys Acta
1357:
234-242,
1997[Medline].
This article has been cited by other articles:
![]() |
S. M. Kelly, J. K. VanSlyke, and L. S. Musil Regulation of Ubiquitin-Proteasome System mediated Degradation by Cytosolic Stress Mol. Biol. Cell, November 1, 2007; 18(11): 4279 - 4291. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Luss, W. Schmitz, and J. Neumann A proteasome inhibitor confers cardioprotection Cardiovasc Res, April 1, 2002; 54(1): 140 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Luo, X. Sun, E. Hungness, and P.-O. Hasselgren Heat shock protects L6 myotubes from catabolic effects of dexamethasone and prevents downregulation of NF-kappa B Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1193 - R1200. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |